Skip to main content

Annals of Hematology

Ausgabe 7/2022

Inhalt (34 Artikel)

Review Article

Extracorporeal membrane oxygenation in patients with hematologic malignancies: a systematic review and meta-analysis

Jackie Jia Lin Sim, Saikat Mitra, Ryan Ruiyang Ling, Chuen Seng Tan, Bingwen Eugene Fan, Graeme MacLaren, Kollengode Ramanathan

Original Article

Congenital asplenia study: clinical and laboratory characterisation of adults with congenital asplenia

Grace I. Butel-Simoes, Penelope Jones, Erica M. Wood, Denis Spelman, Ian J. Woolley, Samar Ojaimi

Original Article

Sequential eradication of Helicobacter pylori as a treatment for immune thrombocytopenia in patients with moderate thrombocytopenia: a multicenter prospective randomized phase 3 study

Boram Han, Hyo Jung Kim, Ho-Young Yhim, Doyeun Oh, Sung Hwa Bae, Ho-Jin Shin, Won-Sik Lee, JiHyun Kwon, Jeong-Ok Lee, Hwa Jung Kim, Soo-Mee Bang

Original Article

Comparison of daily oral iron replacement therapy with every other day treatment in female reproductive age patients with iron-deficiency anemia

Lale Aydın Kaynar, Sanem Gökçen, Ferda Can, Zeynep Arzu Yeğin, Zübeyde Nur Özkurt, Münci Yağcı

Original Article

Does size matter? Two new deletions in the HBB gene cause β0-thalassemia

Paloma Ropero, Fernando Ataúlfo González Fernández, Jorge M. Nieto, Valle Recasens, Ángeles Montañés, María José Murúzabal, María Sarasa, Cristina Fernández, Ana Villegas, Cuesta C. Benavente

Original Article

Left atrial deformation indices in β-thalassemia major patients

Dimitrios Patsourakos, Constantina Aggeli, Konstantinos A. Gatzoulis, Sophia Delicou, Yannis Dimitroglou, Katerina Xydaki, Christina Fragodimitri, Aristeidis Androulakis, Konstantinos Tsioufis

Original Article

Screening for hereditary spherocytosis in daily practice: what is the best algorithm using erythrocyte and reticulocyte parameters?

Anne-Sophie Adam, Frédéric Cotton, Brigitte Cantinieaux, Sara Benyaich, Béatrice Gulbis

Original Article

Clinical characteristics and outcomes of 100 adult patients with pure red cell aplasia

Xuemei Wu, Lang Cheng, Xiaoqing Liu, Yu Sun, Bingzong Li, Guangsheng He, Jianyong Li

Original Article

Characteristics of Sweet syndrome in patients with or without malignancy

Eun Hee Jung, Jin Hyun Park, Ki Hwan Kim, Jin-Soo Kim, In Sil Choi, Ja Min Byun, Youngil Koh, Dong-Yeop Shin, Junshik Hong, Sung-Soo Yoon, Hyunkyung Park, Inho Kim

Original Article

Comparative efficacy and safety of eleven induction chemotherapy regimens for young adult patients with newly diagnosed acute myeloid leukemia: a network meta-analysis

Yiqing Li, Ting Tang, Jie Xiao, Boqi Li, Wenjuan Yang, Shuangfeng Xie, Yumo Du, Kezhi Huang, Danian Nie

Original Article

Comprehensive comparison of international prognostic indexes for follicular helper T-cell lymphoma

Yong-Pyo Lee, Sang Eun Yoon, Junhun Cho, Young Hyeh Ko, Hyunji Jo, Seok Jin Kim, Won Seog Kim

Open Access Original Article

Risk prediction of CMV reactivation after allogeneic stem cell transplantation using five non-HLA immunogenetic polymorphisms

Miren Vallejo, Paula Muñiz, Mi Kwon, Laura Solán, Rebeca Bailén, Diego Carbonell, María Chicano, Julia Suárez-González, Pilar Catalán, José María Bellón, Juan Carlos Triviño, Nieves Dorado, David Gallardo, José Luis Díez-Martín, Natalia Ramírez, Carolina Martínez-Laperche, Ismael Buño

Letter to the Editor

A rare case of acute megakaryoblastic leukemia with t(11;17)(q23;q21) and KMT2A::MLLT6 fusion

Lianqun Qiu, Cesar A. Nunez, Guilin Tang, Branko Cuglievan, Ghayas C. Issa, Sa A. Wang, L Jeffrey Medeiros, Beenu Thakral

Letter to the Editor

Chronic neutropenic colitis with complete colonic obstruction in a patient with severe congenital neutropenia associated with G6PC3 mutations

Taxiarchis Konstantinos Nikolouzakis, Konstantinos Spyridakis, Maria Tzardi, Grigorios Tsaknakis, Maria Ximeri, Maksim Klimiankou, Emmanuel Chrysos, Julia Skokowa, Helen A. Papadaki

Open Access Letter to the Editor

Durable response of therapy-related MDS/AML with concomitant Waldenström’s macroglobulinemia treated with venetoclax and azacitidine

Mitsuhito Hirano, Mikako Tamba, Norihito Inoue, Michiru Ikegami, Naoki Onda, Yuko Shirouchi, Yuko Ishihara, Hitoshi Abe, Noriko Nishimura, Yuko Mishima, Kengo Takeuchi, Dai Maruyama

Letter to the Editor

Red eye and visual loss in a bone marrow transplant recipient

Magdalena Corona-Lapuerta, Fernando Martin-Moro, Ana Lario, María Dolores Pérez-Bañón, Juan de Dios Caballero, Jesús Fortún, Javier López

Letter to the Editor

Two cases of refractory IgG4-related disease successfully treated with tocilizumab

Jeremy Ong, Susan Brown, Michael Gilbertson, George Grigoriadis, Ian Simpson, Shahla Vilcassim, Michael Low, Pasquale Fedele, Olga Motorna, Lynden Roberts, Michael Gingold, Gareth Gregory

Letter to the Editor

Anhidrosis associated with long-term use of hydroxyurea in a patient with myeloproliferative neoplasm

Saad Sabbagh, Kawthar Jarrah, Rayan Bou-Fakhredin, Dana Saadeh, Ali T. Taher

Letter to the Editor

A case report of BCR-ABL1 rearrangement in de novo adult T-cell lymphoblastic leukemia/lymphoma with normal karyotype

Weijia Fu, Aijie Huang, Gusheng Tang, Jianmin Yang, Xiong Ni

Letter to the Editor

Combination therapy with low doses of ponatinib and steroids in elderly and frail patients with Philadelphia chromosome-positive acute lymphoblastic leukemia

Takafumi Tsushima, Nobue Sato, Yong-Mei Guo, Satoshi Uchiyama, Hirotaka Nakamura, Akihito Nagata, Chi Song-Gi, Nobuhiko Yamauchi, Yosuke Minami, Junichiro Yuda

Zur Zeit gratis COVID-19 Letter to the Editor

COVID-19: impact of vaccination in myeloma patients

E. Hoornaert, F. Dachy, A. Hansenne, S. Bailly, A. van Maanen, D. Gruson, M-C. Vekemans

Letter to the Editor

Polatuzumab vedotin combined with rituximab-bendamustine immediately before stem cell mobilization in relapsed diffuse large B-cell lymphoma

Teruhito Takakuwa, Yusuke Okayama, Hirohisa Nakamae, Masatomo Kuno, Yosuke Makuuchi, Naonori Harada, Hiroshi Okamura, Mitsutaka Nishimoto, Yasuhiro Nakashima, Hideo Koh, Masayuki Hino

Letter to the Editor

Prognostic impact of Auer rods for cytoreductive chemotherapy and myeloablative allogeneic stem cell transplantation in adult patients with myelodysplastic syndrome with excess blasts-2

Yi Wang, Yaoyao Shen, Jiaqian Qi, Jia Chen, Yang Xu, Feng Chen, Xiao Ma, Miao Miao, Shengli Xue, Huiying Qiu, Xiaowen Tang, Yue Han, Suning Chen, Aining Sun, Yanming Zhang, Depei Wu, Ying Wang

Letter to the Editor

Successful treatment for diffuse large B-cell lymphoma in a Japanese adolescent with PIK3CD germ-line mutation: stem cell transplantation after reduced-intensity conditioning

Hiroshi Yagasaki, Maiko Hirai, Koji Kanezawa, Masaru Ueno, Hiroyuki Hao, Shinobu Masuda, Masahiko Sugitani, Ichiro Morioka

Letter to the Editor

The unexpected impact of cabozantinib on red blood cells consumption in patients with transfusion-dependent thalassemia

Silvia Costantini, Antonella Meloni, Anna Spasiano, Patrizia Cinque, Paolo Ricchi

Correction

Correction to: Relapse with plasmacytoma after upfront autologous stem cell transplantation in multiple myeloma

Tan-Huy Chu, Sung-Hoon Jung, Kihyun Kim, Jae Hoon Lee, Yeung-Chul Mun, Soo-Mee Bang, Dok Hyun Yoon, Ho Sup Lee, Chang-Ki Min, Je-Jung Lee

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Perioperative Checkpointhemmer-Therapie verbessert NSCLC-Prognose

28.05.2024 NSCLC Nachrichten

Eine perioperative Therapie mit Nivolumab reduziert das Risiko für Rezidive und Todesfälle bei operablem NSCLC im Vergleich zu einer alleinigen neoadjuvanten Chemotherapie um über 40%. Darauf deuten die Resultate der Phase-3-Studie CheckMate 77T.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.